Skip to main content
SpringerLink
Log in

De medicamenteuze behandeling van stemstoornissen

juni 2001

  • Chapter
Stemstoornissen

  • 859 Accesses

Samenvatting

Wanneer een bovenste luchtweginfectie zich uit door keelpijn is er een ontsteking van het slijmvlies van farynx en/of tonsillen en/of het proximale deel van de larynx. Pas wanneer er (ook) stemverandering optreedt, is er sprake van (echte) laryngitis; de ontsteking is dan doorgedrongen tot het niveau van de stemplooien.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatuur

  • Adams, R.A., & Victor, M. (1989). Principles of Neurology (4th ed).[] McGraw–Hill Information Services Company, 54–62; 937–943. ISBN 0–07–100122–0.

    Google Scholar 

  • Adams, S.G., e.a. (1993). Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results. Journal of Otolaryngology, 22: 171–175.

    Google Scholar 

  • Adams, S.G. e.a. (1995). Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia. Journal of Otolaryngology, 24: 345–351.

    Google Scholar 

  • American Academy of Neurology (1990). Report of the Therapeutics and Technology Assessment Subcommittee. Assessment the clinical usefulness of botulinum toxin–A in treating neurological disorders. Neurology, 40: 1332–1336.

    Google Scholar 

  • Anonymus (2000). Pariet, protonpompremmer. Geneesmiddelen bulletin, 34: 61.

    Google Scholar 

  • Aronson, A.E. & DeSanto, L.W. (1983). Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection. Laryngoscope, 93: 1–8.

    Google Scholar 

  • Berendse, H.W. (2000). Wat is de plaats van dopamine–agonisten bij de behandeling van de ziekte van Parkinson, afzonderlijk en in combinatie? Neurologen vademecum nr. 7/8 (juli/augustus).

    Google Scholar 

  • Blitzer, A. e.a. (1988). Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (Spastic Dysphonia). Laryngoscope,98: 193–197.

    Google Scholar 

  • Blitzer, A., e.a. (1992). Abductor laryngeal dystonia: a series treated with botulinum toxin. Laryngoscope, 102: 163–167.

    Google Scholar 

  • Blitzer, A., e.a. (1998). Botulinum toxin management of spasmodic dysphonia (Laryngeal Dystonia): a 12–year experience in more than 900 patients. Laryngoscope, 108: 1435–1441.

    Google Scholar 

  • Blitzer, A, & Brin, M.F. (1992). Treatment of spasmodic dysphonia (Laryngeal Dystonia) with local injections of botulinum toxin. Journal of Voice, 6: 365–369.

    Google Scholar 

  • Boermeester, M.A., Sandick, J.W., Lanschot, J.J.B. van, Boeckxstaens, G.E., e.a. (1998). Gastro–oesofageale tefluxziekte: pathofysiologie, diagnostiek en medicamenteuze therapie. Ned.Tijdschrift Geneeskunde, 142: 1306–1310.

    Google Scholar 

  • Bouvy, M. (1994). Farmacotherapie bij ziekte van Parkinson. Geneesmiddelen Bulletin, 28: 44–47.

    Google Scholar 

  • Bough, I.D., Satalof; R.T., Casteel, D.O., Hills, J.R., Gideon, R.M., & Spiegel, J.R. (1995). Gastroesophageal reflux laryngitis risistant to omeprazole therapy. Journal of Voice., 9: 205–211.

    Google Scholar 

  • Brin, M.F., e.a. (1989). Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox). Movement Disorders, 4: 287–296.

    Google Scholar 

  • Brin, M.F., e.a. (1998). Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Advances in Neurology 78: 237–252.

    Google Scholar 

  • Buchholz, D. W., & Neumann, S. (1997). Comments on selected dysphagia litterature. Dysphagia, 12: 57–60.

    Google Scholar 

  • Capper, M.P., Smit, C.F., Stanojcic, L.D., Devtiese, P.P., e.a. (2000). High incidence of laryngopharyngeal reflux in patients with head and neck cancer. The Laryngoscope, 110: 1007–1011.

    Google Scholar 

  • Cohen, J.R., Sataloff; R.T., Spiegel, J.R., Fish, J.F., e.a. (1991). Airway reactivity–induced asthma in singers (arias). Journal of Voice, 5, 332–337.

    Google Scholar 

  • Comella, C.L., e.a. (1992). Dysphagia after botulinum toxin injections for spasmodic torticollis. Neurology, 42: 1307–1310.

    Google Scholar 

  • Critchy, E.M.R. (1981). Speech disorders of Parkinsonism: a review. Journal of Neurology, Neurosurgery and Psychiatry, 44: 751–758.

    Google Scholar 

  • Dedo, H.H. (1976). Recurrent laryngeal nerve section for spastic dysphonia. Annals of Otology, Rhinology & Laryngology, 85: 451–459.

    Google Scholar 

  • Deenstra, M. (1992). De inhalatie als toedieningsvorm van geneesmiddelen. Geneesmiddelen bulletin, 26: 44–47.

    Google Scholar 

  • Devriese, P.P. (1994). Stemband–dyskinesieën. In: Aspecten van stemstoomissen. Rapport Werkgroep Foniatrie Nederlandse Vereniging voor K.N.O.–Heelkunde en Heelkunde van het Hoofd–Halsgebied, 119–128.

    Google Scholar 

  • Devriese, P.P., & Speelman, J.D. (1994). Behandeling van stemband–dyskinesieën. Nederlands Tijdschrift voor Geneeskunde, 138: 944–947.

    Google Scholar 

  • Devriese, P.P. Botuline, een tweesnijdend zwaard. (1998). Geschiedenis der Geneeskunde, 5: 293–299.

    Google Scholar 

  • Devriese, P.P. (1999). Botulinum toxin in adductor spasmodic dysphonia. Injection technique and results. Proceedings 24th IALP–Congress, Amsterdam 1998. Dejonckere, P.H.O. & Peters, H.F.M. (Eds.). University Press, Nijmegen, 302–304.

    Google Scholar 

  • Diagnosrisch Kompas 1999–2000. College voor Zorgverzekeringen. Keelpijn, acute, 238–239.

    Google Scholar 

  • Farmacotherapeutisch Kompas 2000/2001. College voor Zorgverzekeringen: Overige middelen voor astma en copd, 513–515; Mucolytica, oraal, 515–519; Middelen bij hoest en verkoudheid, 484–489; Analgetica, 926–962; Middelen bij infectieziekten, Antibiotica, 697–747; Middelen bij allergische aandoeningen, Antihistaminica, 1064–1073; Glucocorticoïden, 841–850.

    Google Scholar 

  • Farmacotherapeutisch Kompas 2000/2001. College Voor zorgverzekeringen, Anxiolytica, 69–72; Benzodiazepinen, 72–81; Antidepressiva, 110–132; Bèta–receptorblokkerende sympathicolytica, 282–299.

    Google Scholar 

  • Farmacotherapeutisch Kompas 2000/2001. College voor zorgverzekeringen. Parkinsonmiddelen, 153–166.

    Google Scholar 

  • Farmacotherapeutisch Kompas 2000/2001. VI Tracrus Digestivus, 415–439.

    Google Scholar 

  • Ford, C.N., e.a. (1992). Botulinum toxin treatment of spasmodic dysphonia: techniques, indications, efficacy. Journal of Voice, 6: 370–376.

    Google Scholar 

  • Fritzell, B., e.a. (1993). Long–term results of recurrent laryngeal nerve resection or adductor spastic dysphonia. Journal of Voice, 7: 172–178.

    Google Scholar 

  • Gamboa, J., Jiminez–Jeminez, F., Nieto, A., Montojo, J., Orti–Paraja, M., Molina, A., e.a. (1997). Journal of Voice, 3: 314–320.

    Google Scholar 

  • Gates, G., & Montalbo, Ph.J. (1987). The effect of low–dose ß–blockade on performance anxiety in singers. Journal of Voice, 1: 105–108.

    Google Scholar 

  • Gates, G.A., Saegert, J., Wilson, N., Johnson, L., Shepherd,A., & Hearne, E.M. (1985). Annals Otol. Rhino. Laryngol., 94: 570–574.

    Google Scholar 

  • Green, D.C., e.a. (1992). Point–touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia. Annals of Otology, Rhinology & Laryngology, 101: 883–887.

    Google Scholar 

  • Hacki, T., Kenklies, M., Hofman, R., e.a.. (1990). Pharmakotherapie von Stimm– und Artikulationsstorungen bei Aphasie. Folia Phoniatrica, 42: 283–288.

    Google Scholar 

  • Hanson, D.G., Garrat, B.R., Ward, P.H., & Los Angelas, C.A. (1984). Cinegraphic observations of laryngeal function in Parkinson's disease. Laryngoscope, 94: 348–353.

    Google Scholar 

  • Hanson, D.G., Jiang, J.J., Chen, J., e.a. (1997). Acoustic measurement of change in voice quality with treatment for chronic posterior laryngitis. Ann. Otologyl, Rhinology Laryngo1ogy, 106: 279–285.

    Google Scholar 

  • Hartley, L.R., Ugapen, S., Davie, I., & Spencer, D.J. (1983). The effect of beta–adrenergic blocking drugs on speakers' performance and memory. British Journal Psychiatry, 142: 512–517.

    Google Scholar 

  • Hollinger, L.E. (1986). Pharmacotherapeutic considerations in anxiety disorders. Journal Clonical Psychiatry, 47 (Suppl. June): 33–36.

    Google Scholar 

  • Holzer, S.E., & Ludlow, C.L. (1996). The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia. Laryngoscope, 106: 86–92.

    Google Scholar 

  • Izdebski, K., e.a. (1981). Postoperative and follow–up studies of spastic dysphonia patients treated with recurrent laryngeal nerve section. Otolaryngol. Head Neck Surgery, 89: 96–101.

    Google Scholar 

  • Jansen, E.N.H., & Laar, T. van (1990). ‘Oude wijn in nieuwe zakken’; therapie mer subcurane apomorfine bij de ziekre van Parkinson. Ned. Tijdschrift voor Geneeskunde, 134: 889–891.

    Google Scholar 

  • Jiang, J., Lin, E., Wang, J., e.a. (1999). Glottografic measures before and after Levodopa treatment in Parkinson's disease. The Larynoscope, 109: 1287–1294.

    Google Scholar 

  • Jong, de P.T.V.M., e.a. (1991). Vijftien jaar therapeutisch toepassen van botuline A toxine. In: J.C. van Es, E. Mandema, G. Olthus, E. Verstraete (red.), Het Medisch Jaar 1991. Houten/Antwerpen: Bohn Stafleu Van Loghum, 274–277.

    Google Scholar 

  • Klinkenberg–Knol, E.C. (1992). The role of omeprazole in healing and prevention of reflux disease. Hepatogastroenterology, 39 (Suppl 1): 27–30.

    Google Scholar 

  • Klinkenberg–Knol, E.C., Festen, H.P.M., Jansen, J.B.M., Lamers, C.B.H.W., e.a. (1994). Long–term treatment with omeprazol for refractory reflux esophagitis: efficacy and safety. Anno Intern Med. 121: 161–167.

    Google Scholar 

  • Kobayashi, T., e.a. (1993). Botulinum toxin treatment for spasmodic dysphonia. Acta Oto–Laryngologica (Suppl. 504): 155–157.

    Google Scholar 

  • Kompoliti, K., Wang, Q.E., Goetz, C.G., Leurgans, S., & Raman, R. (2000). Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology, 54: 458–462.

    Google Scholar 

  • Koriwchak, M.J., e.a. (1996). Alternating unilateral botulinum toxin type A (BotoX) injections for spasmodic dysphonia. Laryngoscope, 106: 1476–1481.

    Google Scholar 

  • Koufman, J.A. (1991). The otolaryngologic manifestation of gastroesophageal reflux disease (gerd): a clinical investigation of 225 patients using ambulatoty 24–hours pH monitoring and an experimental investigation of the role of acid and pepsin in the development oflaryngeal injuty. The Laryngoscope, 101 (Supp1 53): 1–78.

    Google Scholar 

  • Kumazawa, H., Asako, M.,Yamashita, T., e.a. (1997). An increase in laryngeal aerosol deposition by ultrasonic nebulizer therapy with interrnitrend vocalisation. The Larynsoscope, 107: 671–674.

    Google Scholar 

  • Lader, M. (1988). ß–Adrenoceptor antagonists in neuropsychiatry: An update. Journal Clincal. Psychiatr.,49: 213–223.

    Google Scholar 

  • Langeveld, T.P. (1998). Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia. Annals of Otology, Rhinology & Laryngology, 107: 280–284.

    Google Scholar 

  • Levine, H.L., e.a. (1979). Recurrent laryngeal nerve section for spasmodic dysphonia. Annals of Otology & Laryngology, 88: 527–530.

    Google Scholar 

  • Liu, T.C., e.a. (1996). Prospective study of patients' subjective responses to botulinum toxin injections for spasmodic dysphonia. Journal of Otolaryngology, 25: 66–74.

    Google Scholar 

  • Liu, C.Y. (1998). Emotional Symptoms are secundary to the voice disorder in patients with spasmodic dysphonia. General Hospital Psychiatry, 20: 255–259.

    Google Scholar 

  • Ludlow, C.L., e.a. (1988). Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology, 38: 1220–1225.

    Google Scholar 

  • Ludlow, C.L., e.a. (1992). A comparison of injection techniques using botulinum toxin injection for treatment of the spasmodic dysphonias. Journal of Voice, 6: 380–386.

    Google Scholar 

  • Lundy, D.S. (1998). The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia. Journal of Voice, 12: 460–466.

    Google Scholar 

  • Miller, R.H., e.a. (1987). Botulinum toxin injection of the vocal cord for spasmodic dysphonia. A preliminary report. Archives of Otolaryngology – Head and Neck Surgery, 113: 603–605.

    Google Scholar 

  • Murry, T., & Woodson, G.E. (1995). Combined–modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy. Journal of Voice, 9: 460–465.

    Google Scholar 

  • Perry, P.J., Alexander, B., & Liskow, B.I. (1997). Psychiatric Drug Handbook(7th. ed.)Antianxiety Agents (Anxiolytics)–ß–Blockers, 330–331. ISBN 0–88048–851–4.

    Google Scholar 

  • Ramig, L.O. & Verdolini, K. (1998). Treatment efficacy: voice disorders. Speech and Hearing Research, 41: 101–116.

    Google Scholar 

  • Rhew, K., e.a. (1994). Technique for injection of botulinum toxin through the flexible nasolaryngoscope. Otolaryngology – Head & Neck Surgery, 111: 787–794.

    Google Scholar 

  • Roos, R.A.C., Laar, T. van & Hilren, J.J. van (1994). Beperkte waarde van de apomorfinetest bij de ziekte van Parkinson. Ned. Tijdschrift voor Geneeskunde, 138: 1374–1377.

    Google Scholar 

  • Schalén, L., Eliasson, I., Kamme, C., e.a. (1993). Erythromycin in acute laryngitis in adults. An. Otol. Rhinol. Laryngologie, 102: 209–214.

    Google Scholar 

  • Scott, A.B. (1980). Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87: 1044–1049.

    Google Scholar 

  • Sellin, C. (1981). The action of botulinum toxin at the neuromuscular junction. Medical Bio1ogy, 59: 11–20.

    Google Scholar 

  • Shaw, G.Y., & Searl, J.P. (1997). Laryngeal rnanifestation of gastroesophageal reflux before and after treatment with omeprezole. South Med Journal,90: 1115–1122.

    Google Scholar 

  • Speelman, J.D., e.a. (1996). Neurological indications for botulinum treatment. Proceedings of Biomedical Aspects of Clostridial Neurotoxins. Ranter, H.S. (ed.). Oxford Conference 1996. camr, 85–88.

    Google Scholar 

  • Tewary, A.K. (1996). Correlation between clinical response and injection quality in treatment of spasmodic dysphonia. Journal of Laryngology & Otology, 110: 551–553.

    Google Scholar 

  • Tison, F., Wiart, L., Guatterie, M., Fouiller, N., Lozano, V., e.a. (1996). Effect of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease. Moving Disorders, 11: 729–732.

    Google Scholar 

  • Toogood, J.H. (1990). Complications of topical steroid therapy for asthma. Am. Rev. Respir. Des., 141: 89–96.

    Google Scholar 

  • Toogood, J.H., Jennings, B., Greenway, R.W., e.a. (1980). Journal Allergy, Clinical Immunology, 65: 145–153.

    Google Scholar 

  • Truong, D.D, e.a. (1991). Double–blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope, 101: 630–634.

    Google Scholar 

  • Uijen, J.H.J.M., Ponsioen, B.P., & Jongste, J.C. (1994). Inhalatiemedicatie: toedieningsvormen en hulpmiddelen. Een literatuuronderzoek. Huisarts en Wetenschap, 37: 194–197.

    Google Scholar 

  • Van Ermengem E. (1897). Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus. Zeitschrift für Hygiene und Infektionskrankheiten (Leipzig), 26: 1–56.

    Google Scholar 

  • Whurr, R., e.a. (1993). The use of botulinum toxin in the treatment of adductor spasmodic dysphonia. Journal of Neurology, Neurosurgery & Psychiatry, 56: 526–530.

    Google Scholar 

  • Whurr, R., e.a. (1995). Comparison of dosage effects between the American and British botulinum toxin A products in the treatment of spasmodic dysphonia (abstract). Movement Disorders, 10: 387.

    Google Scholar 

  • Wijngaarden, H.A. van (1977). De invloed van geluid op het neerslaan van ingeademde nevel. Proefschrift. Utrecht: Rijksuniversiteit te Utrecht.

    Google Scholar 

  • Wijngaarden, H.A. van (1983). De behandeling van acute stemklachten door laryngitis. Logopedie en Foniatrie, 55: 389–393.

    Google Scholar 

  • Wijngaarden, HA. van, Hoekstra, A., Damsté, P.H., & Fokkens, J.K. (1978). Is it useful to apply aerosol therapy for laryngeal diseases? Niet–gepubliceerd onderzoekverslag.

    Google Scholar 

  • Williams, A.J., Baghar, M.S., Stableforth, D.E., e.a. (1983). Dysphonia caused by inhalation steroids: recognition of a characretistic laryngeal abnormality. Thorax, 38: 813–821.

    Google Scholar 

  • Wilson, J.A., White,A., Haacke, N.P. von, Maran, A.G.D., Heading, R.C., Pryde, A., & Pris, J. (1989). Gastroesophageal reflux and posterior laryngitis. Anno Oto. Rhino. Laryngol, 98: 405–410.

    Google Scholar 

  • Wiltink, E.H.H., e.a. (1992). Botuline: een toxine als therapeuticum. Pharmaceutisch Weekblad, 127: 1037–1041.

    Google Scholar 

  • Wolters, E.Ch, & Groenewegen, H.J. (1996). Neurologie: Structuur, functie en dysfunctie van het zenuwstelsel. Houten: Bohn Stafleu Van Loghum.

    Google Scholar 

  • Yin, S.S., e.a. (1997). Major patterns of laryngeal electromyography and their clinical application. Laryngoscope, 107: 126–136.

    Google Scholar 

  • Yorkston, K.M. (1996). Treatment efficacy: dysarthria. Journal Speech and Hearing Research, 39: S46–57.

    Google Scholar 

  • Zwirner, P., e.a. (1993). A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia. European Archives of Oto–Rhino–Laryngology, 250: 271–276.

    Google Scholar 

Aanbevolen literatuur

  • Blitzer, A., e.a. (1992). Neurolgic Disorders of the Larynx. NewYork: Thieme.

    Google Scholar 

  • Brin, M.F., e.a. (1998). Laryngeal dystonia (Spasmodic Dysphonia): Observations of 901 patients and treatment with botulinum toxin. Advances in Neurology, 78: 237–252.

    Google Scholar 

Download references

Authors
  1. H.F.M. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Bastiaanse
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Van Borsel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P.H.O. Dejonckere
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Jansonius-Schultheiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sj. Van der Meulen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B.J.E. Mondelaers
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

H.F.M. Peters R. Bastiaanse J. Van Borsel P.H.O. Dejonckere K. Jansonius-Schultheiss Sj. Van der Meulen B.J.E. Mondelaers

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Bohn Stafleu van Loghum, onderdeel van Springer Media

About this chapter

Cite this chapter

Peters, H. et al. (2014). De medicamenteuze behandeling van stemstoornissen. In: Peters, H., et al. Stemstoornissen. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-368-0808-8_42

Download citation

  • DOI: https://doi.org/10.1007/978-90-368-0808-8_42

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Online ISBN: 978-90-368-0808-8

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation